Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: Impact of the SYNTAX scores I and II in patients with diabetes and multivessel coronary disease: a pooled analysis of patient level data from the SYNTAX, PRECOMBAT, and BEST trials, European Heart Journal, April 2017, Oxford University Press (OUP),
DOI: 10.1093/eurheartj/ehx138.
You can read the full text:
Contributors
The following have contributed to this page
